The MECT1-MAML2 Gene Fusion and Benign Warthin's Tumor: Is the MECT1-MAML2 Gene Fusion Specific to Mucuepidermoid Carcinoma?
- 31 July 2006
- journal article
- other
- Published by Elsevier BV in The Journal of Molecular Diagnostics
- Vol. 8 (3), 394-396
- https://doi.org/10.2353/jmoldx.2006.060020
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Molecular classification of mucoepidermoid carcinomas—Prognostic significance of the MECT1–MAML2 fusion oncogeneGenes, Chromosomes and Cancer, 2006
- Clear cell hidradenoma of the skin—a third tumor type with a t(11;19)‐associated TORC1–MAML2 gene fusionGenes, Chromosomes and Cancer, 2005
- ETV6–NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineagesSeminars in Cancer Biology, 2005
- A Study of MECT1-MAML2 in Mucoepidermoid Carcinoma and Warthin's Tumor of Salivary GlandsThe Journal of Molecular Diagnostics, 2004
- t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathwayNature Genetics, 2003
- Mucoepidermoid Carcinoma Involving Warthin TumorAmerican Journal of Clinical Pathology, 2000
- Mucinous differentiation in adnexal sweat gland tumorsJournal of Cutaneous Pathology, 1996
- Cytogenetic observations in 13 cystadenolymphomas (Warthin's tumors)Cancer Genetics and Cytogenetics, 1994
- Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid glandCancer Genetics and Cytogenetics, 1988
- Mucoepidermoid carcinoma of the stomachJournal of Surgical Oncology, 1987